Aveanna Healthcare Reports 22.2% Revenue Growth to $621.9 Million in Latest Quarter

Aveanna Healthcare Holdings, Inc. reported significant financial growth in its latest quarterly filing, with revenues reaching $621.9 million for the three-month period ending September 27, 2025, a 22.2% increase from $509.0 million in the same period last year. For the nine-month period, revenue totaled $1.77 billion, up 17.7% from $1.50 billion in the prior year. The company achieved a net income of $14.1 million for the third quarter, a substantial turnaround from a net loss of $42.8 million in the same quarter of 2024. Year-to-date, net income was $46.3 million, compared to a loss of $40.1 million in the previous year.

The company's operational performance was bolstered by a 25.6% increase in revenue from its Private Duty Services (PDS) segment, which accounted for $514.4 million of the total revenue. This growth was attributed to a 12.9% increase in service volume and a 12.7% rise in revenue rates, driven by reimbursement rate increases from state Medicaid programs and the integration of Thrive Skilled Pediatric Care, acquired in June 2025. The Home Health & Hospice (HHH) segment also saw a 15.3% revenue increase, while the Medical Solutions (MS) segment experienced a slight decline of 0.5%.

Operationally, Aveanna reported a gross margin of $202.8 million, representing 32.6% of revenue, an increase from 31.4% in the prior year. The company’s Field contribution, a non-GAAP measure, rose to $107.4 million, or 17.3% of revenue, up from 14.0% a year earlier. This improvement was attributed to a decrease in branch and regional administrative expenses as a percentage of revenue, which fell to 15.3% from 17.3%. However, corporate expenses increased significantly, rising 63% to $52.0 million, primarily due to professional services related to refinancing efforts and integration costs associated with the Thrive acquisition.

Aveanna's balance sheet showed total assets of $1.81 billion as of September 27, 2025, up from $1.66 billion at the end of the previous fiscal year. The company reported cash and cash equivalents of $145.9 million, alongside patient accounts receivable of $312.8 million. Total liabilities increased slightly to $1.80 billion, with long-term obligations amounting to $1.29 billion. The company’s debt restructuring efforts included a refinancing amendment to its credit agreement, which is expected to lower interest expenses moving forward.

Looking ahead, Aveanna anticipates continued growth driven by its strategic initiatives and the integration of recent acquisitions. However, the company also faces challenges, including potential reimbursement rate reductions from regulatory changes and the competitive landscape of the healthcare industry. The management remains focused on leveraging its operational efficiencies and expanding its service offerings to sustain its growth trajectory.